Safer treatment for acute stroke

The safety of a controversial clot busting drug has been investigated by researchers at The George Institute for Global Health, with results showing a modified dosage can reduce serious bleeding in the brain and improve survival rates.

It is hoped the findings from the trial of more than 3000 patients in 100 hospitals worldwide could change the way the most common form of stroke is treated globally.